☆ 4.7 Article

Real-World Efficacy and Safety of an 8-Week Glecaprevir/Pibrentasvir Regimen in Children and Adolescents with Chronic Hepatitis C-Results of a Multicenter EpiTer-2 Study

JOURNAL OF CLINICAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study

Tatsuki Mizuochi et al.

Summary: This study assessed the real-world efficacy and safety of glecaprevir and pibrentasvir (G/P) treatment in Japanese adolescents with chronic hepatitis C virus (HCV). The results showed that G/P treatment was highly efficacious and well tolerated, with all patients achieving sustained virologic response at 12 weeks after treatment completion.

JOURNAL OF GASTROENTEROLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023

Krzysztof Tomasiewicz et al.

Summary: The recommendations provide guidelines for the diagnosis and treatment of hepatitis C virus (HCV) infection based on the latest knowledge. The main objective of HCV treatment is to eradicate the virus from the body, leading to the cessation or reversal of liver damage. The current guidelines prioritize pangenotypic regimens and offer recommendations for special patient populations, including children, patients with cirrhosis, HIV and HBV co-infection, renal failure, liver failure, lack of response to previous therapies, and patients in the peri-transplant period.

CLINICAL AND EXPERIMENTAL HEPATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

Sarah Blach et al.

Summary: This study aims to evaluate the burden of hepatitis C virus (HCV) in 2020 and forecast the burden by 2030. Using literature review, Delphi process, and mathematical modelling, it estimated the global prevalence of viraemic HCV infection to be 0.7% in 2020, corresponding to 56.8 million infections. The findings suggest that the current efforts are not on track to achieve the global elimination targets by 2030.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy

Ken Sato et al.

Summary: This study demonstrates that treatment of chronic hepatitis C in Japanese adolescents with direct-acting antivirals (DAAs) can achieve sustained virological response without adverse events or laboratory abnormalities, and can improve emotional functioning of patients and their mothers.

CLINICAL CASE REPORTS (2022)

Add to Collection

Article Multidisciplinary Sciences

The impact of treatment on the psychological burden of mothers of children with chronic hepatitis C virus infection: a multicenter, questionnaire survey

Tomoya Fukuoka et al.

Summary: This study assessed the impact of treating children with chronic hepatitis C virus infection on the psychological burden of their mothers. The results showed that successful treatment greatly reduced mothers' concerns about their children's HCV infection.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Pediatrics

Treatment of Chronic Hepatitis C in Young Children Reduces Adverse Outcomes and Is Cost-Effective Compared with Deferring Treatment to Adulthood

Emma Greenaway et al.

Summary: Treating young children with chronic hepatitis C virus (HCV) early is cost-effective, as it can prevent cases of cirrhosis, hepatocellular carcinoma, and liver-related deaths. The study developed a state-transition model and conducted a cost-effectiveness analysis comparing treatment at age 6 years vs delaying treatment until age 18 years. Delaying treatment results in an increased lifetime risk of late-stage liver complications, supporting policies that broaden HCV treatment access to young children.

JOURNAL OF PEDIATRICS (2021)

Add to Collection

Review Gastroenterology & Hepatology

Seroprevalence of Hepatitis C in Children Without Identifiable Risk-Factors: A Systematic Review and Meta-Analysis

Vasiliki Melikoki et al.

Summary: The prevalence of HCV in children is substantial, with viremic infection being an important factor. Despite potential underdiagnosis, the epidemiological data of HCV in children remains significant.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2021)

Add to Collection

Article Gastroenterology & Hepatology

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study

Maureen M. Jonas et al.

Summary: The pediatric formulation of GLE/PIB was highly effective and well tolerated in children aged 3 to < 12 years with chronic HCV infection.

HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines

Farihah Malik et al.

Summary: This study highlighted significant gaps in policies for testing and treating HCV-infected children and adolescents in many countries, emphasizing the urgent need for advocacy and updated guidelines specific to this population.

JHEP REPORTS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Global prevalence of hepatitis C virus in children in 2018: a modelling study

Jonathan Schmelzer et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Three Children Treated with Direct-acting Antivirals for Chronic Hepatitis C Virus Genotype 1b Infection

Kazuki Ohya et al.

INTERNAL MEDICINE (2020)

Add to Collection

Review Gastroenterology & Hepatology

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020

Waldemar Halota et al.

CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Viral hepatitis in children and adolescents 2 Hepatitis C virus infection in children and adolescents

Giuseppe Indolfi et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Epidemiology and natural history of hepatitis C virus infection among children and young people

Line Modin et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study

Maureen M. Jonas et al.

HEPATOLOGY

Add to Collection

© Peeref 2019-2024. All rights reserved.